3 Clinical psychopharmacology3.2 Pharmacokinetics

3.2.1.3 Protein binding

1 min read1 figure

Written by Resident Doctor Committee · Published

Binding proteins

Protein

Binds

Examples

Albumin

Acidic and neutral drugs

Valproate, phenytoin, diazepam

Alpha-1-acid glycoprotein

Basic lipophilic drugs

Most antipsychotics, tricyclics

  • Binding is reversible, and bound drug dissociates quickly to replace free drug.

  • The unbound fraction is the unbound concentration divided by the total: a drug 90% bound has an unbound fraction of 0.10.

  • Only unbound drug crosses membranes such as the blood-brain barrier, reaches receptors and produces a response.

Binding to albumin is reversible, and only the unbound drug crosses the capillary wall to reach receptors, while bound drug stays in plasma as a reservoir. Drawn for MRCPsychiatrist

Binding of individual drugs

Drug

Plasma protein binding

Diazepam

About 98 to 99%, mainly to albumin

Sertraline

About 98%

Fluoxetine, paroxetine

Above 90%

Citalopram, fluvoxamine

About 77 to 80%

Escitalopram

About 56%, the lowest SSRI

Duloxetine and most other antidepressants

85 to 98%

Venlafaxine

About 27%

Desvenlafaxine, venlafaxine's metabolite

About 30%

Lithium

Unbound

  • Desmethyldiazepam (nordazepam) is the main active metabolite of diazepam.

Volume of distribution

  • Plasma binding and tissue binding move the apparent volume of distribution (Vd) in opposite directions.

  • Bound drug is held in the circulation, so less plasma binding lets more drug reach the tissues and raises Vd.

  • Tissue binding can dominate: fluoxetine distributes widely despite high plasma binding.

Displacement and low albumin

  • Displacement interactions matter clinically only when binding capacity is reduced, as in renal disease with proteinuria and hypoalbuminaemia, when the unbound fraction of a highly bound drug rises.

  • Otherwise the displaced drug is distributed and eliminated faster, so free exposure at steady state changes little.

  • In hypoalbuminaemia the total level falls without a matching fall in active drug, so raising valproate to correct a low total level can cause toxicity.

3.2.1.3 Protein binding | MRCPsychiatrist